Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CRBP – Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings
CRBP
$11.25
Name : Corbus Pharmaceuticals Holdings
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $197,471,648.00
EPSttm : -5.49
finviz dynamic chart for CRBP
Corbus Pharmaceuticals Holdings
$11.25
1.63%
$0.18

Float Short %

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

EPS Last/This Y

-2.36

EPS This/Next Y

1.03

Price

11.25

Target Price

40.3

Analyst Recom

1

Performance Q

23.22

Relative Volume

0.89

Beta

2.73

Ticker: CRBP




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-10-20CRBP18.280.240.3019928
2025-10-21CRBP19.280.250.6121859
2025-10-22CRBP17.720.270.0422174
2025-10-23CRBP17.340.270.7022154
2025-10-24CRBP16.850.271.6022129
2025-10-27CRBP170.280.0222190
2025-10-28CRBP17.030.280.0122022
2025-10-29CRBP16.840.280.2021806
2025-10-30CRBP16.390.280.2821874
2025-10-31CRBP12.160.283.4921884
2025-11-03CRBP12.310.311.4322431
2025-11-04CRBP11.280.3119.3222587
2025-11-05CRBP10.870.350.9923293
2025-11-06CRBP10.460.343.6223185
2025-11-07CRBP10.50.352.6723272
2025-11-10CRBP10.50.350.1323274
2025-11-11CRBP10.450.350.4423370
2025-11-12CRBP11.180.350.5123374
2025-11-13CRBP11.040.350.0023356
2025-11-14CRBP11.080.350.0923361
2025-11-17CRBP11.260.350.0023375
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-10-20CRBP18.28-48.4-22.6-6.42
2025-10-21CRBP19.34-48.4-43.2-6.42
2025-10-22CRBP17.74-48.4-17.8-6.42
2025-10-23CRBP17.40-48.4-28.6-6.42
2025-10-24CRBP16.87-48.4-26.0-6.42
2025-10-27CRBP17.05-48.4-33.7-6.42
2025-10-28CRBP17.12-48.4-33.4-6.42
2025-10-29CRBP16.85-48.4-28.7-6.42
2025-10-30CRBP16.44-48.4-27.0-6.42
2025-10-31CRBP12.15-48.422.0-6.42
2025-11-03CRBP12.31-48.4-35.5-6.42
2025-11-04CRBP11.25-48.4-15.3-6.42
2025-11-05CRBP10.85-48.4-25.3-6.42
2025-11-06CRBP10.46-48.4-23.2-6.42
2025-11-07CRBP10.52-48.4-32.9-6.42
2025-11-10CRBP10.46-48.4-30.0-6.42
2025-11-11CRBP10.42-48.4-30.0-6.42
2025-11-12CRBP11.13-48.4-49.9-6.42
2025-11-13CRBP11.05-48.4-29.9-6.42
2025-11-14CRBP11.06-48.4-31.8-6.42
2025-11-17CRBP11.25-74.9-48.7-6.04
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-10-20CRBP-0.33-9.4310.66
2025-10-21CRBP-0.33-9.4310.66
2025-10-22CRBP-0.41-9.4310.66
2025-10-23CRBP-0.41-9.4310.66
2025-10-24CRBP-0.41-9.4310.66
2025-10-27CRBP-3.49-9.028.97
2025-10-28CRBP-3.49-9.028.97
2025-10-29CRBP-3.49-9.028.97
2025-10-30CRBP-3.49-9.028.97
2025-10-31CRBP-3.49-9.028.97
2025-11-03CRBP-3.06-9.459.13
2025-11-04CRBP-3.06-9.459.13
2025-11-05CRBP-3.06-9.459.13
2025-11-06CRBP-3.06-9.459.13
2025-11-07CRBP-3.06-9.459.13
2025-11-10CRBP-3.06-7.389.13
2025-11-11CRBP-3.06-7.389.13
2025-11-12CRBP-3.06-7.389.72
2025-11-13CRBP-3.06-7.389.72
2025-11-14CRBP-3.06-7.389.71
2025-11-17CRBP-2.17-2.290
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-1.36

Avg. EPS Est. Next Quarter

-1.4

Insider Transactions

-2.17

Institutional Transactions

-2.29

Beta

2.73

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

Fair Value

Quality Score

14

Growth Score

22

Sentiment Score

45

Actual DrawDown %

90.6

Max Drawdown 5-Year %

-97.9

Target Price

40.3

P/E

Forward P/E

PEG

P/S

P/B

1.53

P/Free Cash Flow

EPS

-5.51

Average EPS Est. Cur. Y​

-6.04

EPS Next Y. (Est.)

-5.01

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

Relative Volume

0.89

Return on Equity vs Sector %

-79.2

Return on Equity vs Industry %

-64.2

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.35

EBIT Estimation

-48.7
Corbus Pharmaceuticals Holdings
Sector: Healthcare
Industry: Biotechnology
Employees: 28
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
stock quote shares CRBP – Corbus Pharmaceuticals Holdings, Inc. Stock Price stock today
news today CRBP – Corbus Pharmaceuticals Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRBP – Corbus Pharmaceuticals Holdings, Inc. yahoo finance google finance
stock history CRBP – Corbus Pharmaceuticals Holdings, Inc. invest stock market
stock prices CRBP premarket after hours
ticker CRBP fair value insiders trading